Respiratory ILD Flashcards

1
Q

define ILD/ DPLD

A

group of lung diseases affecting the interstitium (alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissue). ILDs interfere with gas transfer. They cause a restrictive pattern. Symptoms: breathlessness, dry cough. ILD can be acute/ episodic/ chronic (chronic can be part of systemic disease/ due to chronic exposure to an agent/ idiopathic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 main categories of ILD?

A
  1. ILD of known cause e.g.drugs/ collagen vascular disease
  2. Idiopathic Interstitial Pneumonia (IIP)
  3. Granulomatous ILDs e.g. sarcoidosis, EAA
  4. Other forms of ILD e.g. LAM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 8 types of Idiopathic interstitial pneumonia?

A
  1. Idiopathic pulmonary fibrosis
  2. Desquamative interstitial pneumonia
  3. Acute interstitial pneumonia
  4. non-specific interstitial pneumonia
  5. Lymphocytic interstitial pneumonia
  6. Cryptogenic organising pneumonia
  7. IIP other than IPF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Collagen Vascular disease

A

A group of disease which affect the connective tissue (can cause ILD of known origin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Idiopathic pulmonary fibrosis

A

a chronic and ultimately fatal disease characterised by a progressive worsening dyspnea. Poor prognosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Desquamative interstitial pneumonia

A

Form of IPF featuring elevated levels of macrophages. Name is derived from former belief that these macrophages were pneumocytes (alveolar cells) that had been desquamated. This disease is associated with people who have smoking history.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Respiratory bronchiolitis interstitial lung disease

A

Associated with smoking.
This is a histological finding, not a pathological description. Appearance is similar to that of desquamative interstitial pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute interstitial pneumonia

A

Rare, severe, usually affects otherwise health individuals. No known cause or cure, often characterised as an ILD, but is also a form of ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cryptogenic organising pneumonia (AKA bronchiolitis obliterans organising pneumonia (BOOP))

A

inflammation of the bronchioles and surrounding tissue of the lugs. Often a complication of existing inflammatory disease e.g. rheumatoid arthritis. “Organising” refers to unresolved pneumonia (the alveolar exudate persists and eventually undergoes fibrosis). That phase of resolution/ remodelling following bacterial infections is commonly referred to as organising pneumonia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-specific interstitial pneumonia (NSIP)

A

2 different disease patterns with different prognoses: cellular, and fibrosing. Cellular pattern has chronic inflammation and minimal fibrosis. Fibrosing pattern has interstitial fibrosis with various inflammation levels. Both patterns are uniform and lack the prominent fibroblastic foci that are found in other types of IIP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lymphocytic interstitial pneumonia

A

A syndrome secondary to autoimmune and other lymphoproliferative disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sarcoidosis

A

Disease involving abnormal collections of inflammatory cells that form lumps known as granulomas. Granulomas are non-caseating - unknown aetiology (but probably infective agent in susceptible individual, imbalance of immune system with type 4 hypersensitivity). LESS common in smokers. There is genetic pre-disposition for sarcoidosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

LAM (Lymphangioleiomyomatosis)

A

Rare, progressive and systemic disease that results in cystic lung destruction. Mostly affects women of child-bearing age. Lung destruction is consequence of diffuse infiltrationof neoplastic smooth muscle-like cells, which invade all lung structures including lymphatics, airway walls, blood vessels, and interstitial spaces. Consequences of obstruction of vessels and airways include chylous fluid accumulations, haemoptysis, airflow obstruction, pneumothorax.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical features of acute sarcoidosis

A

-erythema nodosum
-bilateral hilar lymphadenopathy
-arthritis
-uveitis
-parotitis
-fever
The disease often settles in a couple of months without treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical features of chronic sarcoidosis

A
  • lung infiltrates (alveolitis)
  • skin infiltrations
  • peripheral lymphadenopathy
  • hypercalcaemia
  • other organs: renal, myocardial, neurological, hepatitis, splenomegaly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Key difference between TB and sarcoidosis? (Both are granulomatous).

A

TB is infective, unlike sarcoidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Differential Diagnosis of Sarcoidosis

A
  • TB: but TB is infective
  • Carcinoma: lung cancer often spreads to lymph nodes, giving high calcium and enlarger hilar
  • fungal infection?
  • Do a blood test (ACE levels raised in granulomatous diseases), check CRP, plasma viscosity, raised calcium
18
Q

Treatment of acute sarcoidosis

A

no treatment

steroids if vital organ affected

19
Q

Treatment of chronic sarcoidosis

A

oral steroids usually needed, immunosuppression

20
Q

Extrinsic Allergic Alveolitis (EAA) AKA hypersensitivity pneumonitis

A

inflammation of the alveoli casued by type 3 hypersensitivity reaction to allergen (inhaled dusts)
caused by thermophilic actinomycetes e.g. farmer’s lung, avian antigens (bird fancier’s lung), drugs
No cause identified in 30% cases. Can be acute or chronic

21
Q

Clinical features and treatment of acute EAA

A

cough, breathless, fever, myalgia, symptoms occur hours after exposure, crackles (no wheeze), hypoxia, CXR shows widespread pulmonary infiltrates
Treatment: oxygen, steroid, antigen avoidance

22
Q

Clinical features and Treatment of Chronic EAA

A

may be crackles, clubbing is unusual (unlike other types of pulmonary fibrosis), CXR shows pulmonary fibrosis (mostly in upper zones), PFTs are restrictive.
Diagnosis: history, preciptins (IgG to specific antien(s)), lung biopsy if in doubt
Treatment: remove antigen exposure, oral steroids if breathless or low gas transfer

23
Q

Idiopathic pulmonary fibrosis

A

most important of all the ILDs. More common in smokers and in men
Aetiology unknown: could be imbalance of fibrotic repair system/ related to gastric reflux
It is NOT an inflammatory disease.
Secondary causes could be: rheumatoid/ SLE/ systemic sclerosis/ asbestos/ drugs
Doesn’t respond to anti-inflammatories (since it’s not an inflammatory disease)

24
Q

Clinical features of IPF

A

progressive breathlessness, dry cough, clubbing, bilateral fine inspiratory crackles, restrictive pattern, reduced lung volumes, low gas transfer
CXR shows bilateral infiltrates
CT shows reticulonodular fibrotic shadowing, worse at lung bases and periphery, traction bronchiectasis (subtype of bronchiectasis in which there is irreversible dilation of bronchi and bronchioles in areas of pulmonary fibrosis or distorted lung parenchyma), honey-combing cystic changes. Lung biopsy not necessary if CT diagnostic

25
Q

Diagnosis of IPF

A

Differential diagnosis: must exclude occupational disease, connective tissue disease, LV failure, sarcoidosis, EAA
Ask about occupation, pets, drug history
Do examination and maybe HRCT
If HRCT atypical - do lung biopsy

26
Q

pathology of IPF

A

heterogeneous fibrosis in alveolar walls with fibroblastic foci and destruction of architecture causing honeycombing. Inflammation is minimal. Lung volume shrinks because scars tend to pull everything in

27
Q

Treatment of IPF

A

steroids and immunosuppressants don’t change disease course
New anti-fibrotic drugs (nintedanib and pirfenidone) slow progression but are expensive
fibrosis cannot be reversed, just slowed.
oxygen can be given if hypoxic
lung transplants for young patients

28
Q

simple pneumoconiosis

A

does not cause impairment of lung function. There is CXR abnormality.

29
Q

Complicated pneumoconiosis

A

Progressive massive fibrosis, and there is restrictive pattern with breathlessness.

30
Q

What causes chronic bronchitits?

A

coal dust

smoking

31
Q

Caplan’s syndrome AKA rheumatoid pneumoconiosis (pulmonary nodules)

A

a combination of rheumatoid arthritis and pneumoconiosis that manifests as intrapulmonary nodules, which appear homogeneous and well-defined on CXR

32
Q

What’s an example of simple pneumoconiosis?

A

silicosis
15-20 years exposure to quartz
few symptoms
CXR abnormal (egg-shell calcification of hilar nodes)
chronic silicosis: has restrictive pattern, pulmonary fibrosis. There is nodular appearance through the lungs

33
Q

What’s an example of complicated pneumoconiosis (progressive massive fibrosis)?

A

Coal worker’s lung

There will be restrictive pattern, breathlessness, splodges of fibrosis on CXR

34
Q

Name some asbestos-related lung disorders

A
  • pleural disease
  • pulmonary fibrosis “asbestosis”
  • bronchial carcinoma
35
Q

asbestosis (pulmonary fibrosis)

A

chronic inflammation and scarring disease affecting the tissue of the lungs. SOB and increased risk of cancer. Looks like IPF on CXR. Asbestosis is NOT an IPF because the cause can be determined from history.

36
Q

explain the “synergistic effect” of smoking and asbestos exposure

A

If you smoke and have had exposure to asbestos: the risk for lung cancer is not additive, but MULTIPLIED

37
Q

bronchial carcinoma

A

asbestos multiplies the risk in smokers

38
Q

mesothelioma

A

incurable pleural cancer
Patients have chest pain and pleural effusion. Cannot operate. All treatment symptomatic and palliative. Takes 20/30 years to develop after exposure.

39
Q

Benign pleural plaques

A

are markers of asbestos exposure on CXR. In themselves, they are not harmful. These plaques can calcify over time

40
Q

Acute asbestos pleuritis

A

fever, pain, bloody pleural effusion

41
Q

pleural effusion and diffuse pleural thickening

A

restrictive impairment